Revolution Medici…
USUSDRevolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 1. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
Par uzņēmumu
- Tīmekļvietne
- revmed.com
- Investoru attiecības
- revmed.com/investors/
- Nozare
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Galvenā mītne
- REDWOOD CITY, United States
- Izpilddirektors
- Mark A. Goldsmith
- Darbinieki
- 883
- Dibināts
- 2014
- Apgrozībā esošās akcijas
- 214.34 milj. uz 2026-07-31
- Brīvā apgrozība
- 184.5 milj.
- Tirgus kapitalizācija
- 43.24 mljrd. USD
- Iekšējās personas
- 1.85%
- Institucionālie investori
- 101.01%
- Nozare (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US76155X1000
- LEI
- 549300JU3X0LBCQ65892
- FCF
- −1.23 mljrd. USD
- Parāds
- 0
- Peļņa un FCF — par 12 mēnešiem līdz 30.06.2026 (uzņēmuma jaunākais ziņojums).
Apraksts
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Biržas un tikeri
| Birža | Tikeris | Valūta | Cena | Veids |
|---|---|---|---|---|
| US USA Stocks | RVMD | USD | 188.12 -6.35% | parastās akcijas |
Ziņas šonedēļ
Ziņu no uzņēmuma vietnes vēl nav.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| Blackrock Inc. | 6.39% | 13.7 milj. | 2026-06-30 |
| Farallon Capital Managem… | 6.32% | 13.55 milj. | 2026-06-30 |
| FMR, LLC | 5.69% | 12.2 milj. | 2026-06-30 |
| Baker Bros. Advisors, LP | 5.34% | 11.44 milj. | 2026-06-30 |
| Jupiter Topco LLC | 5.01% | 10.74 milj. | 2026-06-30 |
| Darwin Global Management… | 4.96% | 10.63 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 4.24% | 9.09 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.87% | 8.29 milj. | 2026-06-30 |
| Nextech Invest, Ltd. | 3.55% | 7.6 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.99% | 6.41 milj. | 2026-06-30 |
| Paradigm Biocapital Advi… | 2.97% | 6.36 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.16% | 4.63 milj. | 2026-06-30 |
| Growth Fund of America | 1.38% | 2.96 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.25% | 2.67 milj. | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.15% | 2.47 milj. | 2026-07-31 |
| BORISY ALEXIS (Director) | ≈1.09% | 2.34 milj. | 2026-06-18 |
| VANGUARD INDEX FUNDS-Van… | 1.07% | 2.29 milj. | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.84 milj. | 2026-04-30 |
| iShares Trust-iShares Bi… | 0.65% | 1.39 milj. | 2026-07-31 |
| JPMorgan Trust II-JPMorg… | 0.54% | 1.17 milj. | 2026-06-30 |
| iShares Trust-iShares Ru… | 0.51% | 1.1 milj. | 2026-07-31 |
| GOLDSMITH MARK A (Chief… | ≈0.46% | 984 238 | 2026-08-21 |
| KELSEY STEPHEN MICHAEL (… | ≈0.14% | 291 876 | 2026-09-11 |
| HORN MARGARET A (Chief O… | ≈0.07% | 154 647 | 2026-06-17 |
| ANDERS JACK LEE (Chief F… | ≈0.06% | 123 269 | 2026-06-24 |
| WANG XIAOLIN (Officer) | ≈0.05% | 116 063 | 2026-03-17 |
| LIN WEI (Officer) | ≈0.05% | 101 366 | 2026-03-17 |
| HORNING SANDRA (Director… | ≈0.05% | 97 765 | 2026-06-18 |
| CISLINI JEFFREY TODD (Ge… | ≈0.03% | 55 907 | 2026-08-21 |
| SCHROEDER THILO (Directo… | — | — | 2024-12-05 |
Pieslēdzies ar Google